I

InnoCan Pharma
INNO

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
CA$52.64M
EV
CA$48.11M
Shares Outstanding
292.42M
Beta
3.01

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About InnoCan Pharma Corporation

gainify

I

InnoCan Pharma Corporation

INNO

InnoCan Pharma Corporation, a pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally. The company oper...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Bincovich, Iris

Employees

IPO Date

2019-09-25

Headquarters

1015, 926 – 5 Avenue SW, Calgary, Alberta, T2P 0N7, Canada

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved